NSCLC exhibits significant overexpression of BMP2 compared to normal lung tissue and benign tumors, and depletion of BMP2 or its receptor BMPR2 has been shown to reduce cell migration and invasiveness (Wu et al. 2022). The gene discussed is BMP2; the disease is non-small cell lung carcinoma.